Clinical Trial Update: Vorinostat in Treating Patients With Metastatic Melanoma of the Eye [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Vorinostat in metastatic uveal melanoma of the eye. The study is sponsored by the National Cancer Institute and is currently a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveal Melanoma

Drugs mentioned

• Zolinza (vorinostat)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Metastatic Uveal Melanoma, Stage IV Uveal Melanoma AJCC v7 | Phase 2 | Status: ACTIVE_NOT_RECRUITING